Annual CFF
-$2.82 M
-$2.29 M-428.58%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual cash flow from financing activities is currently -$2.82 million, with the most recent change of -$2.29 million (-428.58%) on 31 December 2023. During the last 3 years, it has fallen by -$157.70 million (-101.82%). CRBP annual CFF is now -101.82% below its all-time high of $154.87 million, reached on 31 December 2020.CRBP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$25.04 M
-$9.92 M-28.37%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly cash flow from financing activities is currently $25.04 million, with the most recent change of -$9.92 million (-28.37%) on 30 September 2024. Over the past year, it has increased by +$25.86 million (+3150.43%). CRBP quarterly CFF is now -76.50% below its all-time high of $106.58 million, reached on 31 March 2024.CRBP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$164.69 M
+$25.86 M+18.63%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM cash flow from financing activities is currently $164.69 million, with the most recent change of +$25.86 million (+18.63%) on 30 September 2024. Over the past year, it has increased by +$165.37 million (+24258.21%). CRBP TTM CFF is now -4.45% below its all-time high of $172.35 million, reached on 31 March 2021.CRBP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -428.6% | +3150.4% | +10000.0% |
| 3 y3 years | -101.8% | +10000.0% | +101.3% |
| 5 y5 years | -124.7% | +10000.0% | +332.1% |
CRBP Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.8% | at low | -76.5% | +1415.0% | at high | +5938.9% |
| 5 y | 5 years | -101.8% | at low | -76.5% | +1415.0% | -4.5% | +5938.9% |
| alltime | all time | -101.8% | at low | -76.5% | +1415.0% | -4.5% | +5938.9% |
Corbus Pharmaceuticals Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $25.04 M(-28.4%) | $164.69 M(+18.6%) |
| June 2024 | - | $34.96 M(-67.2%) | $138.82 M(+33.6%) |
| Mar 2024 | - | $106.58 M(-5696.4%) | $103.88 M(-3782.9%) |
| Dec 2023 | -$2.82 M(+428.6%) | -$1.90 M(+132.0%) | -$2.82 M(+313.7%) |
| Sept 2023 | - | -$821.00 K(-4661.1%) | -$681.70 K(-2483.6%) |
| June 2023 | - | $18.00 K(-115.9%) | $28.60 K(-109.0%) |
| Mar 2023 | - | -$113.00 K(-148.2%) | -$319.50 K(-40.1%) |
| Dec 2022 | -$533.60 K(-100.9%) | $234.30 K(-311.7%) | -$533.60 K(<-9900.0%) |
| Sept 2022 | - | -$110.70 K(-66.5%) | $0.00(-100.0%) |
| June 2022 | - | -$330.10 K(+0.9%) | $8000.00(-90.3%) |
| Mar 2022 | - | -$327.10 K(-142.6%) | $82.50 K(-99.9%) |
| Dec 2021 | $60.82 M(-60.7%) | $767.90 K(-847.7%) | $60.82 M(-25.6%) |
| Sept 2021 | - | -$102.70 K(-59.8%) | $81.79 M(-36.4%) |
| June 2021 | - | -$255.60 K(-100.4%) | $128.62 M(-25.4%) |
| Mar 2021 | - | $60.41 M(+178.0%) | $172.35 M(+11.3%) |
| Dec 2020 | $154.87 M(+302.7%) | $21.73 M(-53.5%) | $154.87 M(+15.7%) |
| Sept 2020 | - | $46.73 M(+7.5%) | $133.89 M(+53.7%) |
| June 2020 | - | $43.47 M(+1.3%) | $87.14 M(+100.4%) |
| Mar 2020 | - | $42.93 M(+5604.0%) | $43.47 M(+13.0%) |
| Dec 2019 | $38.46 M | $752.70 K(-3159.8%) | $38.46 M(+0.9%) |
| Sept 2019 | - | -$24.60 K(-87.1%) | $38.11 M(+0.1%) |
| June 2019 | - | -$191.20 K(-100.5%) | $38.07 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $37.93 M(+9306.4%) | $38.22 M(+234.7%) |
| Dec 2018 | $11.42 M(-85.0%) | $403.20 K(-726.1%) | $11.42 M(-75.5%) |
| Sept 2018 | - | -$64.40 K(+36.2%) | $46.61 M(-0.0%) |
| June 2018 | - | -$47.30 K(-100.4%) | $46.62 M(+0.2%) |
| Mar 2018 | - | $11.13 M(-68.7%) | $46.53 M(-38.8%) |
| Dec 2017 | $76.01 M(+354.0%) | $35.59 M(<-9900.0%) | $76.01 M(+80.6%) |
| Sept 2017 | - | -$58.00 K(-58.0%) | $42.09 M(-0.5%) |
| June 2017 | - | -$138.00 K(-100.3%) | $42.30 M(-26.3%) |
| Mar 2017 | - | $40.61 M(+2330.1%) | $57.42 M(+243.0%) |
| Dec 2016 | $16.74 M(+54.5%) | $1.67 M(+976.8%) | $16.74 M(+9.9%) |
| Sept 2016 | - | $155.20 K(-99.0%) | $15.23 M(-29.1%) |
| June 2016 | - | $14.99 M(<-9900.0%) | $21.50 M(+99.5%) |
| Mar 2016 | - | -$70.20 K(-143.3%) | $10.78 M(-0.6%) |
| Dec 2015 | $10.84 M(+29.2%) | $162.00 K(-97.5%) | $10.84 M(+1.1%) |
| Sept 2015 | - | $6.42 M(+50.4%) | $10.72 M(+170.0%) |
| June 2015 | - | $4.27 M(<-9900.0%) | $3.97 M(-52.6%) |
| Mar 2015 | - | -$9300.00(-119.6%) | $8.38 M(-0.1%) |
| Dec 2014 | $8.39 M(+6486.9%) | $47.40 K(-114.2%) | $8.39 M(+0.6%) |
| Sept 2014 | - | -$333.10 K(-103.8%) | $8.34 M(-3.8%) |
| June 2014 | - | $8.67 M(>+9900.0%) | $8.67 M(>+9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $127.30 K | - | - |
FAQ
- What is Corbus Pharmaceuticals Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual CFF year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly CFF year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM CFF year-on-year change?
What is Corbus Pharmaceuticals Holdings annual cash flow from financing activities?
The current annual CFF of CRBP is -$2.82 M
What is the all time high annual CFF for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual cash flow from financing activities is $154.87 M
What is Corbus Pharmaceuticals Holdings annual CFF year-on-year change?
Over the past year, CRBP annual cash flow from financing activities has changed by -$2.29 M (-428.58%)
What is Corbus Pharmaceuticals Holdings quarterly cash flow from financing activities?
The current quarterly CFF of CRBP is $25.04 M
What is the all time high quarterly CFF for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly cash flow from financing activities is $106.58 M
What is Corbus Pharmaceuticals Holdings quarterly CFF year-on-year change?
Over the past year, CRBP quarterly cash flow from financing activities has changed by +$25.86 M (+3150.43%)
What is Corbus Pharmaceuticals Holdings TTM cash flow from financing activities?
The current TTM CFF of CRBP is $164.69 M
What is the all time high TTM CFF for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM cash flow from financing activities is $172.35 M
What is Corbus Pharmaceuticals Holdings TTM CFF year-on-year change?
Over the past year, CRBP TTM cash flow from financing activities has changed by +$165.37 M (+24258.21%)